Prawo i regulacje · 20/02/2018

U.S. Federal Trade Commission Approves Pfizer's Acquisition of BioNTech, Following Review of Proposed Transaction

The U.S. Federal Trade Commission has approved Pfizer's acquisition of BioNTech, following a review of the proposed transaction, which was announced in January 2023 and is expected to be completed in the second half of 2023